Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruggeri

Showing results (341-350 of 721) with videos related to

Pageof 73
Sort By:
Epidemiology and Infection|January 9, 2018
Pilot survey of norovirus in Northern Italy: an example of surveillance of norovirus gastroenteritisE Pagani, F Folli, S Tofani, et al.
Clinical and Translational Imaging|March 17, 2021
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic reviewLuca Giovanella, Rosaria M Ruggeri, Petra Petranović Ovčariček, et al.
Science Signaling|February 22, 2022
Arenaviral infection causes bleeding in mice due to reduced serotonin release from plateletsRoberto Aiolfi, Giovanni Sitia, Matteo Iannacone, et al.
European Journal of Haematology|February 1, 1988
Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factorF Rodeghiero, G Castaman, E Di Bona, et al.
Neurobiology of Aging|May 30, 2001
Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypesR Scacchi, M Ruggeri, G Gambina, et al.
Acta Dermato-Venereologica|October 1, 1993
An endocrinological study of patients with primary cutis verticis gyrataR Palazzo, C Schepis, M Ruggeri, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1976
Studies on the prolonged bleeding time in von Willebrand's diseaseP M Mannucci, F I Pareti, L Holmberg, et al.
The New England Journal of Medicine|April 27, 1995
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosisS Cortelazzo, G Finazzi, M Ruggeri, et al.
Blood|June 1, 1982
Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypesZ M Ruggeri, P M Mannucci, R Lombardi, et al.
Clinical Nephrology|November 1, 1981
Factor VIII/von Willebrand factor in glomerular nephropathiesR Coppola, L Guerra, Z M Ruggeri, et al.
Pageof 73

Showing results (341-350 of 721) with videos related to

Sort By:
Pageof 73
Epidemiology and Infection|January 9, 2018
Pilot survey of norovirus in Northern Italy: an example of surveillance of norovirus gastroenteritisE Pagani, F Folli, S Tofani, et al.
Clinical and Translational Imaging|March 17, 2021
Prevalence of thyroid dysfunction in patients with COVID-19: a systematic reviewLuca Giovanella, Rosaria M Ruggeri, Petra Petranović Ovčariček, et al.
Science Signaling|February 22, 2022
Arenaviral infection causes bleeding in mice due to reduced serotonin release from plateletsRoberto Aiolfi, Giovanni Sitia, Matteo Iannacone, et al.
European Journal of Haematology|February 1, 1988
Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factorF Rodeghiero, G Castaman, E Di Bona, et al.
Neurobiology of Aging|May 30, 2001
Plasma alpha1-antichymotrypsin in Alzheimer's disease; relationships with APOE genotypesR Scacchi, M Ruggeri, G Gambina, et al.
Acta Dermato-Venereologica|October 1, 1993
An endocrinological study of patients with primary cutis verticis gyrataR Palazzo, C Schepis, M Ruggeri, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1976
Studies on the prolonged bleeding time in von Willebrand's diseaseP M Mannucci, F I Pareti, L Holmberg, et al.
The New England Journal of Medicine|April 27, 1995
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosisS Cortelazzo, G Finazzi, M Ruggeri, et al.
Blood|June 1, 1982
Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypesZ M Ruggeri, P M Mannucci, R Lombardi, et al.
Clinical Nephrology|November 1, 1981
Factor VIII/von Willebrand factor in glomerular nephropathiesR Coppola, L Guerra, Z M Ruggeri, et al.
Pageof 73